Ypsomed invests over CHF 100 million in Solothurn site expansion

Ypsomed will invest over CHF 100 million over the next four years to expand autoinjector production capacities at its Solothurn site.

“Ypsomed will invest over CHF 100 million over the next four years in the expansion of capacities for autoinjectors at the Solothurn site.”ypsomed.com

• 1 source
• ypsomed.comYpsomed sells its pen needle and BGM business to MTD and invests in the expansion of its Solothurn site - YpsomedMar 27, 2024

Summarized from public sources; check the original articles before acting on it.